Silvia Urbina
Internal Medicine · San Diego, CANPI 1588930895
Payments from drug & device makers
Across 34 payments — averaging $50,297 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$1.5M
- Astrazeneca UK Limited$258K
- AbbVie$145
- AstraZeneca$116
- Takeda Pharmaceuticals U.S.A., Inc.$94
- Intercept Pharmaceuticals, Inc.$16
What the payments were for
- Food & beverage$371100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 28 | $1,451,814 |
| Astrazeneca UK Limited | 1 | $257,910 |
| AbbVie | 2 | $145 |
| AstraZeneca | 1 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $94 |
| Intercept Pharmaceuticals, Inc. | 1 | $16 |
How this compares
$1,710,095 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.
Other internal medicine in San Diego
- Donald BrandonSan Diego$34M
- Elaine WatkinsSan Diego$11.3M
- James ChenSan Diego$2.9M
- Rita StarrittSan Diego$2.6M
- Hatim HusainSan Diego$2.6M
- Gary FiresteinSan Diego$2.6M
- Andrew ChengSouth San Francisco$55.1M
- Joel NeutelTustin$34.9M
- William TownerLos Angeles$27.4M
- Rahul AggarwalSan Francisco$24M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.